	Evaluating the suitability of the Perceive, Recall, Plan and Perform System of Task Analysis (PRPP-A) for assessing work-related cognitive difficulties in women after breast cancer: A comparison with Cambridge Neuropsychological Test Automated Battery (CANTAB). Aust Occup Ther J Lewis J, Mackenzie L, Chapparo C, Ranka J. PMID: 42622509 [PubMed - indexed for MEDLINE]
	Emerging therapeutic strategies for triple-negative breast cancer using ruthenium, iridium, and rhenium complexes. Dalton Trans Das R, Paira P. PMID: 42622453 [PubMed - as supplied by publisher]
	Case Report: When Routine Gynecologic Procedures Unmask a Systemic Bleeding Disorder: Refractory Uterine Hemorrhage Leading to the Diagnosis of AL Amyloidosis. J Obstet Gynaecol Res Genç N, Gönenli MG, Sadri S, Çakmak T, Do, Akay OM. PMID: 42622220 [PubMed - indexed for MEDLINE]
	Assessment of atypical glandular cell interpretation in Pap tests using the Hologic Genius Digital Diagnostics System. Cancer Cytopathol Jones TE, Matsko J, Wu D, Zeng X, Colaizzi A, Brown H, Pantanowitz L, Zhao C. PMID: 42622122 [PubMed - indexed for MEDLINE]
	Clinical Advances in Breast Cancer: A Comprehensive Overview of Full-Course Disease Management. Cancer Innov Peng X, Tan Y, Ma F. PMID: 42621907 [PubMed]
	Food packaging-derived endocrine disruptors and breast cancer nutrition: dietary exposure, estrogen signaling, and survivorship implications. Front Public Health Yang G, Meng X. PMID: 42621883 [PubMed - indexed for MEDLINE]
	Natural Products for Polyendocrine Metabolic Ovarian Syndrome: Integrating Traditional Chinese and Western Medicine Perspectives. Drug Des Devel Ther Deng X, Zhang Y, Zeng H, Shen F, Huang H. PMID: 42621566 [PubMed - indexed for MEDLINE]
	Diversity within ovarian cancer subtypes and their tumor microenvironment. Front Oncol Winstone L, Bevelander B, Chamberlain MD. PMID: 42621564 [PubMed]
	The microbiota-host metabolic axis in cervical cancer: from homeostatic disruption to mechanisms of therapy resistance. Front Cell Infect Microbiol He Y, Zhao Y, Ju S, Zhou P, Si J, Pan Y, Jiang Y. PMID: 42621466 [PubMed - indexed for MEDLINE]
	The chemokine network in triple-negative breast cancer: its role in immune microenvironment regulation, and prospects for targeted therapy. Front Immunol Wang W, Chen L, Guo W, Hu M, Han X, Xia X, Xu W, Ma W. PMID: 42621449 [PubMed - indexed for MEDLINE]
	Complete decongestive therapy for breast cancer-related lymphedema: An evidence summary. Asia Pac J Oncol Nurs Zhu C, Cai M, Li Y, Hou S, Zhang X, Qiu J. PMID: 42621244 [PubMed]
	Metabolic and endometrial ultrasonographic factors associated with clinical pregnancy in PCOS patients undergoing FET: a nomogram development study with internal validation. Front Endocrinol (Lausanne) Cheng X, Xie L, Zhang Y, Tong D, Yang Z, Yu Y, Zhou J. PMID: 42620880 [PubMed - indexed for MEDLINE]
	Age-stratified hormonal profiles in adolescent and young adult PCOS/PMOS: higher mid-adolescent AMH largely unexplained by BMI. Front Endocrinol (Lausanne) Erbey S, Polat M, Erbey B, Kahyao. PMID: 42620613 [PubMed - indexed for MEDLINE]
	Oral herbal medicine for breast cancer-related symptoms: an evidence map of systematic reviews. Front Med (Lausanne) Jun JH, Choi TY, Yang C, Lee HW, Lee MS. PMID: 42620566 [PubMed]
	Acupuncture for ovulation induction in polycystic ovary syndrome: study protocol for a multicenter, randomized, sham-controlled trial. Front Endocrinol (Lausanne) Li J, Li Z, Pei L, Sun J, Wang J, Lu Q, Yang L, Hang T, Qi L, Zhang Q, An D, Su C, Lu G, Yan X, Fang Y, Xu H. PMID: 42620487 [PubMed - indexed for MEDLINE]
	Breast Cancer Risk After Benign Breast Disease Among Racially Diverse Women: Systematic Review and Meta-Analysis. Res Sq Koric A, Preema N, Anandarajah A, Patel S, Hardi A, Colditz GA. PMID: 42620475 [PubMed]
	Effect of tango versus exercise on chemotherapy-induced neuropathy after breast cancer treatment: a Phase II randomized controlled trial. Res Sq Worthen-Chaudhari L, Schnell P, Bland C, Lantis K, Wilder J, Hock K, Alwan A, Hawke A, Bader G, Davenport AP, Gatti-Mays ME, Johnson KC, Quiroga DM, Sardesai SD, Stover DG, Wesolowski R, Williams NO, Crasta JE, Hackney ME, Lustberg MB. PMID: 42620214 [PubMed]
	Response-adaptive breast cancer care in the grey zones: integrating ER and HER2 targeted PET, FDG PET/CT under immunotherapy, and ctDNA kinetics. Explor Target Antitumor Ther Zivanovic J, Zhang-Yin J. PMID: 42620137 [PubMed]
	Circulating tumor DNA concentration at diagnosis is a modifiable prognostic factor for distant metastatic recurrence in patients with high-risk breast cancer receiving neoadjuvant therapy. medRxiv Magbanua MJM, Wolf DM, Yau C, Manon NA, Sayaman RW, Brown Swigart L, Hirst G, Li W, Isaacs C, Shatsky R, Clark AS, Zimmer A, Mukhtar R, Delson AL, Perlmutter J, Pohlmann PR, Hylton NM, Nanda R, Yee D, Symmans WF, Esserman LJ, Rugo HS, DeMichele A, van 't Veer LJ. PMID: 42619946 [PubMed]
	Treatment-Related Toxicities of Antibody-Drug Conjugates in Breast Cancer: A Bayesian Network Meta-Analysis. Cancer Control Han Y, Xu H, Yao Y, Wang Y, Sun C, Nishimura Y, Lin Y, Xu-Welliver M, Ruddy KJ, Mutter RW. PMID: 42619658 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 333908

Page 1 of 16696



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy